AAPL289.85+0.49 (+0.17%) ▲|ABBV249.67-1.97 (-0.78%) ▼|ABT92.66+1.92 (+2.11%) ▲|ACN126.81+2.37 (+1.90%) ▲|ADBE208.69+3.67 (+1.79%) ▲|AMAT688.39-34.62 (-4.79%) ▼|AMD560.27-20.64 (-3.55%) ▼|AMGN362.83+0.71 (+0.19%) ▲|AMT165.40+1.83 (+1.12%) ▲|AMZN236.24-2.11 (-0.88%) ▼|AVGO370.19-7.56 (-2.00%) ▼|AXP339.32+1.07 (+0.32%) ▲|BA218.29+1.82 (+0.84%) ▲|BAC57.45+0.47 (+0.82%) ▲|BKNG180.02+1.78 (+1.00%) ▲|BLK964.15+2.59 (+0.27%) ▲|BMY57.22-0.40 (-0.69%) ▼|BNY145.09+0.48 (+0.33%) ▲|BRK-B500.49+0.10 (+0.02%) ▲|C139.12-0.84 (-0.60%) ▼|CAT1,038.13-26.77 (-2.51%) ▼|CL91.78+0.10 (+0.11%) ▲|CMCSA24.00-0.56 (-2.26%) ▼|COF202.06+1.44 (+0.72%) ▲|COP104.00+0.04 (+0.04%) ▲|COST925.00-10.47 (-1.12%) ▼|CRM163.56+6.90 (+4.40%) ▲|CSCO116.72-0.74 (-0.63%) ▼|CVS103.58+0.13 (+0.13%) ▲|CVX166.48+0.72 (+0.43%) ▲|DE625.06-9.27 (-1.46%) ▼|DHR191.76+1.28 (+0.67%) ▲|DIS97.00+0.75 (+0.77%) ▲|DUK126.33-0.25 (-0.20%) ▼|EMR141.55-1.61 (-1.12%) ▼|FDX315.28+2.15 (+0.69%) ▲|GD359.74+5.50 (+1.55%) ▲|GE374.75+1.02 (+0.27%) ▲|GEV1,151.69-23.17 (-1.97%) ▼|GILD125.78-0.56 (-0.44%) ▼|GM77.20+0.12 (+0.16%) ▲|GOOG353.82+0.49 (+0.14%) ▲|GOOGL357.16-0.22 (-0.06%) ▼|GS1,016.00+4.63 (+0.46%) ▲|HD354.31+1.63 (+0.46%) ▲|HON224.85+0.95 (+0.42%) ▲|IBM286.68+5.47 (+1.95%) ▲|INTC135.25-4.38 (-3.14%) ▼|INTU270.82+9.82 (+3.76%) ▲|ISRG401.82+4.14 (+1.04%) ▲|JNJ252.95-1.02 (-0.40%) ▼|JPM328.29+0.96 (+0.29%) ▲|KO81.62+0.35 (+0.42%) ▲|LIN519.07+0.13 (+0.02%) ▲|LLY1,195.38-4.05 (-0.34%) ▼|LMT518.83+9.37 (+1.84%) ▲|LOW223.16+2.67 (+1.21%) ▲|LRCX408.21-25.12 (-5.80%) ▼|MA514.50+0.90 (+0.18%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.72+0.88 (+1.52%) ▲|MDT79.54+1.31 (+1.67%) ▲|META604.43+41.14 (+7.30%) ▲|MMM160.68-1.23 (-0.76%) ▼|MO72.15+0.20 (+0.28%) ▲|MRK126.86-1.64 (-1.28%) ▼|MS209.85+0.81 (+0.39%) ▲|MSFT376.53+3.51 (+0.94%) ▲|MU1,089.58-64.71 (-5.61%) ▼|NEE87.36-0.37 (-0.42%) ▼|NFLX72.72+1.32 (+1.85%) ▲|NKE42.12+1.08 (+2.62%) ▲|NOW102.66+3.39 (+3.41%) ▲|NVDA195.25-4.84 (-2.42%) ▼|ORCL145.70-0.96 (-0.65%) ▼|PEP139.18+3.78 (+2.79%) ▲|PFE24.11+0.33 (+1.37%) ▲|PG146.41-0.11 (-0.08%) ▼|PLTR123.25+6.58 (+5.64%) ▲|PM179.11-1.74 (-0.96%) ▼|QCOM184.51-0.29 (-0.15%) ▼|RTX189.98+0.32 (+0.17%) ▲|SBUX102.45+0.26 (+0.25%) ▲|SCHW93.35+1.15 (+1.25%) ▲|SO95.66-0.03 (-0.03%) ▼|SPG221.57-2.15 (-0.96%) ▼|T20.81+0.12 (+0.56%) ▲|TMO505.28+4.37 (+0.87%) ▲|TMUS170.88+3.15 (+1.88%) ▲|TSLA422.87+2.27 (+0.54%) ▲|TXN302.33+4.26 (+1.43%) ▲|UBER72.75+0.64 (+0.89%) ▲|UNH418.13+2.78 (+0.67%) ▲|UNP272.74+0.84 (+0.31%) ▲|UPS108.25+0.85 (+0.79%) ▲|USB60.96+0.55 (+0.90%) ▲|V342.20-0.39 (-0.11%) ▼|VZ42.38+0.07 (+0.17%) ▲|WFC84.21+1.57 (+1.90%) ▲|WMT107.91-5.35 (-4.72%) ▼|XOM137.00+0.52 (+0.38%) ▲|AAPL289.85+0.49 (+0.17%) ▲|ABBV249.67-1.97 (-0.78%) ▼|ABT92.66+1.92 (+2.11%) ▲|ACN126.81+2.37 (+1.90%) ▲|ADBE208.69+3.67 (+1.79%) ▲|AMAT688.39-34.62 (-4.79%) ▼|AMD560.27-20.64 (-3.55%) ▼|AMGN362.83+0.71 (+0.19%) ▲|AMT165.40+1.83 (+1.12%) ▲|AMZN236.24-2.11 (-0.88%) ▼|AVGO370.19-7.56 (-2.00%) ▼|AXP339.32+1.07 (+0.32%) ▲|BA218.29+1.82 (+0.84%) ▲|BAC57.45+0.47 (+0.82%) ▲|BKNG180.02+1.78 (+1.00%) ▲|BLK964.15+2.59 (+0.27%) ▲|BMY57.22-0.40 (-0.69%) ▼|BNY145.09+0.48 (+0.33%) ▲|BRK-B500.49+0.10 (+0.02%) ▲|C139.12-0.84 (-0.60%) ▼|CAT1,038.13-26.77 (-2.51%) ▼|CL91.78+0.10 (+0.11%) ▲|CMCSA24.00-0.56 (-2.26%) ▼|COF202.06+1.44 (+0.72%) ▲|COP104.00+0.04 (+0.04%) ▲|COST925.00-10.47 (-1.12%) ▼|CRM163.56+6.90 (+4.40%) ▲|CSCO116.72-0.74 (-0.63%) ▼|CVS103.58+0.13 (+0.13%) ▲|CVX166.48+0.72 (+0.43%) ▲|DE625.06-9.27 (-1.46%) ▼|DHR191.76+1.28 (+0.67%) ▲|DIS97.00+0.75 (+0.77%) ▲|DUK126.33-0.25 (-0.20%) ▼|EMR141.55-1.61 (-1.12%) ▼|FDX315.28+2.15 (+0.69%) ▲|GD359.74+5.50 (+1.55%) ▲|GE374.75+1.02 (+0.27%) ▲|GEV1,151.69-23.17 (-1.97%) ▼|GILD125.78-0.56 (-0.44%) ▼|GM77.20+0.12 (+0.16%) ▲|GOOG353.82+0.49 (+0.14%) ▲|GOOGL357.16-0.22 (-0.06%) ▼|GS1,016.00+4.63 (+0.46%) ▲|HD354.31+1.63 (+0.46%) ▲|HON224.85+0.95 (+0.42%) ▲|IBM286.68+5.47 (+1.95%) ▲|INTC135.25-4.38 (-3.14%) ▼|INTU270.82+9.82 (+3.76%) ▲|ISRG401.82+4.14 (+1.04%) ▲|JNJ252.95-1.02 (-0.40%) ▼|JPM328.29+0.96 (+0.29%) ▲|KO81.62+0.35 (+0.42%) ▲|LIN519.07+0.13 (+0.02%) ▲|LLY1,195.38-4.05 (-0.34%) ▼|LMT518.83+9.37 (+1.84%) ▲|LOW223.16+2.67 (+1.21%) ▲|LRCX408.21-25.12 (-5.80%) ▼|MA514.50+0.90 (+0.18%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.72+0.88 (+1.52%) ▲|MDT79.54+1.31 (+1.67%) ▲|META604.43+41.14 (+7.30%) ▲|MMM160.68-1.23 (-0.76%) ▼|MO72.15+0.20 (+0.28%) ▲|MRK126.86-1.64 (-1.28%) ▼|MS209.85+0.81 (+0.39%) ▲|MSFT376.53+3.51 (+0.94%) ▲|MU1,089.58-64.71 (-5.61%) ▼|NEE87.36-0.37 (-0.42%) ▼|NFLX72.72+1.32 (+1.85%) ▲|NKE42.12+1.08 (+2.62%) ▲|NOW102.66+3.39 (+3.41%) ▲|NVDA195.25-4.84 (-2.42%) ▼|ORCL145.70-0.96 (-0.65%) ▼|PEP139.18+3.78 (+2.79%) ▲|PFE24.11+0.33 (+1.37%) ▲|PG146.41-0.11 (-0.08%) ▼|PLTR123.25+6.58 (+5.64%) ▲|PM179.11-1.74 (-0.96%) ▼|QCOM184.51-0.29 (-0.15%) ▼|RTX189.98+0.32 (+0.17%) ▲|SBUX102.45+0.26 (+0.25%) ▲|SCHW93.35+1.15 (+1.25%) ▲|SO95.66-0.03 (-0.03%) ▼|SPG221.57-2.15 (-0.96%) ▼|T20.81+0.12 (+0.56%) ▲|TMO505.28+4.37 (+0.87%) ▲|TMUS170.88+3.15 (+1.88%) ▲|TSLA422.87+2.27 (+0.54%) ▲|TXN302.33+4.26 (+1.43%) ▲|UBER72.75+0.64 (+0.89%) ▲|UNH418.13+2.78 (+0.67%) ▲|UNP272.74+0.84 (+0.31%) ▲|UPS108.25+0.85 (+0.79%) ▲|USB60.96+0.55 (+0.90%) ▲|V342.20-0.39 (-0.11%) ▼|VZ42.38+0.07 (+0.17%) ▲|WFC84.21+1.57 (+1.90%) ▲|WMT107.91-5.35 (-4.72%) ▼|XOM137.00+0.52 (+0.38%) ▲|
29 C
New York
Wednesday, July 1, 2026

Tag: multimedia

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more...

Adults with type 2 diabetes on semaglutide 1 mg whose dose was increased to 2 mg were as likely to reach an HbA1c level...

Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes

New research supports monthly dosing as a next‑generation opportunity to improve weight lossNEW ORLEANS, June 6, 2026 /PRNewswire/ -- New data highlight the potential...

Chandigarh University holds 8th CU Online Annual Convocation; 363 Students Degrees Awarded

Chandigarh University Sings MoU with Global Consulting Giant PwC to Offer Online MBA Program330 Postgraduate and 33 Undergraduate Degrees Conferred to Online and Distance...

Fox ESS Unveils Dynamic Energy Ecosystem Alongside Its First Rebrand Area at SNEC 2026

SHANGHAI, June 6, 2026 /PRNewswire/ -- Fox ESS, a global leader in renewable energy solutions, successfully concluded SNEC 2026 following the official launch of its...

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast, Bharuch district, GujaratEmployees and communities work together to conserve...

Global Rise in Delayed Childbearing and Infertility Drives Demand for Cross-Border Fertility Care

Asian Case Studies Highlight How Regulation, Cost, and Access Are Shaping International Family ChoicesTAIPEI, June 6, 2026 /PRNewswire/ -- Delayed marriage, postponed childbearing, and...

PICS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PicS N.V. and Announces Opportunity for Investors with Substantial Losses...

SAN DIEGO, June 5, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of PicS N.V. (NASDAQ: PICS) Class A common...

Think Together Awards 2026 Beyond Think Together Scholarships to Ten High School Seniors Across the State

Each recipient received $3,000 to support their future higher education goals.SANTA ANA, Calif., June 5, 2026 /PRNewswire/ -- Think Together, California's largest nonprofit expanded...

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

AMB-702 demonstrates superior target coverage and efficacy in lean non-human primates The dataset was shared as part of a poster presentation at the American Diabetes...

Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes

Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More Advanced Approach to Early IdentificationNEW ORLEANS, June 5,...

Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026

A phase 2 study of investigational once-weekly subcutaneous zenagamtide showed statistically significant reductions in blood sugar in adults with type 2 diabetes compared to...

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney diseaseZHUBEI CITY, Taiwan and RALEIGH, N.C.,...

Corner Bakery Offers $50 Off Catering for Game-Day Watch Parties

Limited-time June offer helps fans feed the crowd during watch parties, game days and summer gatherings.DALLAS, June 5, 2026 /PRNewswire/ -- June is packed...

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin UseNEW ORLEANS, June 5, 2026 /PRNewswire/ -- A...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMultimedia